Body composition and inflammation impact in non-small-cell lung cancer patients treated by first-line immunotherapy.
Baldessari C, Pecchi A, Marcheselli R, Guaitoli G, Bonacini R, Valoriani F, Torricelli P, Reverberi L, Menozzi R, Pugliese G, Vitale MG, Sabbatini R, Bertolini F, Barbieri F, Dominici M.
Baldessari C, et al. Among authors: bertolini f.
Immunotherapy. 2021 Dec;13(18):1501-1519. doi: 10.2217/imt-2021-0038. Epub 2021 Oct 21.
Immunotherapy. 2021.
PMID: 34670403